Organization
Presage Biosciences
4 clinical trials
Clinical trial
A Phase 0 Master Protocol Using the CIVO® Platform to Evaluate Intratumoral Microdoses of Anti-Cancer Therapies in Patients With Solid TumorsStatus: Recruiting, Estimated PCD: 2031-12-01
Clinical trial
TAK-676 Alone and in Combination(s) With Carboplatin, 5-Fluorouracil, and Paclitaxel in Patients With Head and Neck Squamous Cell CarcinomaStatus: Completed, Estimated PCD: 2022-11-15
Clinical trial
Pembrolizumab Alone and in Combination(s) With MK-0482 and MK-4830 Via Intratumoral Injection in Patients With Head and Neck Squamous Cell Carcinoma or Soft Tissue Sarcoma Prior to Planned Surgical InterventionStatus: Completed, Estimated PCD: 2023-06-22
Clinical trial
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of Rilvegostomig, Volrustomig, and SabestomigStatus: Recruiting, Estimated PCD: 2024-12-01